Observational studyWorld journal of gastroenterology2025

Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study.

Maria Tzouvala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.